Tag: cancer

Full list of foods that have red dye 3 in them as FDA bans substance over cancer links

The FDA announced today it was banning the use of red 3 dye in foods in America, telling thousands of manufacturers to strip it from their products.

Food and drink makers have until January 2027 to reformulate their recipes or be forced out of the market.

The FDA agency said it was taking the action as a ‘matter of law’ because some studies have found that the dye caused cancer in lab rats. 

‘The FDA is taking action that will remove the authorization for the use of… Red No. 3 in food and ingested drugs,’ said Jim Jones, the FDA’s deputy commissioner for human foods. 

The dye has been used for decades to give candy, soda, and other foods and vibrant, cherry-red hue. It was banned from cosmetics by the FDA about three decades ago.  

There is no indication so far that food manufacturers will challenge the new rule, and they will have sufficient time to adjust their products to meet the new standards.

There is some concern that manufacturers may opt to use red 40, which, along with red 3, has been associated with various health concerns.

Keep reading

US bans popular red dye from foods — 35 years after it was banned in cosmetics

The FDA today has issued an order today that will ban Red No. 3 from food products and ingested drugs.

The dye, which was approved for use in 1907, has been banned in cosmetics and topical drugs since 1990 over evidence that it can cause cancer. Its use in food is already banned or restricted in Australia, Japan, and countries in the EU.

Red No. 3. is commonly found in candy, gum and cookies, including Brach’s candy corn, Betty Crocker sprinkles and strawberry Ensure.

Food manufacturers will have until Jan. 15, 2027, to remove it from all products, while makers of ingested drugs will have until Jan. 18, 2028.

The new ban is based on the Delaney Clause of the Federal Food, Drug, and Cosmetic Act, which was enacted in 1960.

Keep reading

TURBO-CANCER, HEARTBREAK & TOXIC SPIKE. Lethal Risks from Covid mRNA Vaccines

The COVID-19 pandemic has led to a widespread use of vaccines, whose adverse and/or unwanted effects have been deliberately ignored, and at best underestimated by those doctors who have amnesia have forgotten the oath of Hippocrates.

In this article we summarize the scientific evidence on adverse effects and how much have influenced in our lives the COVID vaccines, research carried out by doctors and researchers published in PEER REVIEW on international medical journals, and finding out whether or not these effects are significant.

Three different studies leading to one result.

Oncologist Gentilini: “Turbo-Cancer Alarm from Vaccines”

The first of these studies that we will observe, is that of Dr Patrizia Gentilini, an oncologist who for over 30 years worked in the oncology department in Forlì (Emilia-Romagna).
In a passage of his work, the former Chief of Oncology states:

“The use of mRNA vaccines in the context of infectious diseases is unprecedented and many are still unknown in this regard, since it is not clear from which cells of the body, after inoculation, the protein Spike is produced, how much it is produced, how long and where it is distributed”.

So, the Spike protein could represent a danger to those who have accepted the vaccination requirement imposed by law.

Keep reading

U.S. Allows This Food Additive in Breads, Cakes and Ice Cream — But It’s Banned in Europe

Titanium dioxide is the most widely used whitening pigment in the world and has been linked to adverse health effects, particularly genotoxicity and intestinal inflammation.

It is applied as a food coloring and a whitening agent to a wide variety of foods, including chewing gum, cakes, candies, breads and ice cream.

Because of health risks, France banned titanium dioxide, or TiO2, as a food additive in 2020. Two years later the European Union (EU) also banned titanium dioxide as a food additive.

But in the U.S., titanium dioxide is found all over the grocery shelves.

Candy like Skittles, Starbursts and Jell-O, gum like Trident White peppermint gum and Mentos Freshmint Gum, cake products like Duncan Hines Creamy Vanilla Frosting and Nabisco Chips Ahoy! cookies are just a few of the myriad food items that contain the additive.

A significant body of research, mostly from rodent models and in vitro studies, has linked titanium dioxide with health risks related to the gut, including intestinal inflammation, alterations to the gut microbiota and more.

It is classified by the International Agency for Research on Cancer in Group 2B, as possibly carcinogenic to humans.

As a food additive, titanium dioxide and its nanoparticles in particular have been associated with DNA damage and cell mutations, which in turn, have the potential to cause cancer. When used as a food coloring, it is known as E171.

With the rise of nanotechnology, research in recent years has also shown the dangers of titanium dioxide or TiO2 nanoparticles, and their genotoxicity, which refers to a chemical agent’s ability to harm or damage DNA in cells, thus potentially causing cancer.

Keep reading

Covid Vaccines Contain Cancer Virus Fragments & Mutagenic DNA Contamination — Study

A peer-reviewed study published Sunday documented findings from Covid gene-therapy vaccine analysis conducted in the BSL-1 research facility at the FDA White Oak campus. The findings detailed how the mRNA injections contain fragments of SV40 cancer virus, as well as DNA contamination.

“Using 4 vials of experimental mRNA vaccines, we found that two out of four vials of those experimental mRNA vaccines contained residual plasmid DNA that transformed Escherichia coli cells. We subsequently applied our method to assess 2 separate lots of Pfizer COVID-19 mRNA vaccines and found no replication-competent plasmid DNA. However, these authorized vaccines do contain residual DNA to a level that exceeds 10 ng per dose,” the study said in the ‘Abstract’ section.

While SV40 cancer virus fragments were detected, the researchers stated that since it was just fragments it’s unlikely they’d have the same carcinogenic effect as fully intact SV40 cancer viruses, yet may still cause localized reactions.

It should be noted however that other researchers have detected larger SV40 cancer virus fragments in their mRNA Covid vaccine samples.

“Although some investigators have reported the presence of larger DNA fragments with SV40 promoter/enhancer from the commercial mRNA vaccines (18), our results showed the efficient digestion of plasmid DNA in Pfizer COVID-19 mRNA vaccines,” the study said in the ‘Discussion’ section. “Since we only detected DNA fragments < 35 bp in our study, it is practically unlikely for these broken pieces of SV40 promoters to be functional. The plasmid DNA template does not contain oncogenes. Therefore, it is less likely that these DNA fragments will be oncogenic or infectious. Smaller DNA fragments can be immunostimulatory, contributing to local reactions after vaccination.”

Perhaps ironically, the impetus of this study was to “report a simple method to detect residual replication-competent plasmid DNA that is present in mRNA vaccines as impurities” in order to “suggest that stringent and transparent monitoring of DNA impurity may aid in the buildup of public trust in mRNA vaccines.”

Keep reading

Microplastics Linked to Cancer and Harm to Human Reproductive, Digestive, and Respiratory Systems

Last week, the study titled Effects of Microplastic Exposure on Human Digestive, Reproductive, and Respiratory Health: A Rapid Systematic Review by Chartres et al was published in the journal Environmental Science and Technology:

Microplastics are ubiquitous environmental contaminants for which there are documented human exposures, but there is a paucity of research evaluating their impacts on human health. We conducted a rapid systematic review using the “Navigation Guide” systematic review method.

We searched four databases in July 2022 and April 2024 with no restriction on the date. We included studies using predefined eligibility criteria that quantitatively examined the association of microplastic exposure with any health outcomes. We amended the eligibility criteria after screening studies and prioritized digestive, reproductive, and respiratory outcomes for further evaluation.

We included three human observational studies examining reproductive (n= 2) and respiratory (n = 1) outcomes and 28 animal studies examining reproductive (n = 11), respiratory (n = 7), and digestive (n = 10) outcomes. For reproductive outcomes (sperm quality) and digestive outcomes (immunosuppresion) we rated overall body evidence as “high” quality and concluded microplastic exposure is “suspected” to adversely impact them. For reproductive outcomes (female follicles and reproductive hormones), digestive outcomes (gross or microanatomic colon/small intestine effects, alters cell proliferation and cell death, and chronic inflammation), and respiratory outcomes (pulmonary function, lung injury, chronic inflammation, and oxidative stress) we rated the overall body of evidence as “moderate” quality and concluded microplastic exposure is “suspected” to adversely impact them. We concluded that exposure to microplastics is “unclassifiable” for birth outcomes and gestational age in humans on the basis of the “low” and “very low” quality of the evidence.

We concluded that microplastics are “suspected” to harm human reproductive, digestive, and respiratory health, with a suggested link to colon and lung cancer. Future research on microplastics should investigate additional health outcomes impacted by microplastic exposure and identify strategies to reduce exposure.

Keep reading

“I Thought He Was Helping Me”: Patient Endured 9 Years of Chemotherapy for Cancer He Never Had

Anthony Olson wanted a career, children, a partner with whom he could hike Montana’s trails. Despite the diabetes diagnosis at age 4, the anemia, the kidney transplant that failed at age 29, the dialysis, he clung to those dreams. He attended community college and later moved from his parents’ house in Helena to study accounting at Montana Tech in Butte. He thought he might live a nearly normal life.

All of that was taken away in early 2011 when an oncologist at St. Peter’s, Helena’s only hospital, diagnosed him with myelodysplastic syndrome, a blood disorder that’s often described as pre-leukemia. The life expectancy of MDS patients is short. “He told me that without treatment, I’d be dead before the end of the year,” Olson said. He was 33.

“That diagnosis changed the direction of my life,” Olson, now 47, told me.

Olson couldn’t have known that he was one of many patients who, according to court records, may have received inappropriate, harmful or unnecessary treatments from Dr. Thomas C. Weiner. As I reported earlier this month, administrators at St. Peter’s suspected Weiner, who directed the hospital’s cancer center, was hurting patients for years. Yet hospital administrators allowed him to keep treating people until late 2020, when they suspended and then fired him. Weiner has denied all the allegations.

“I trusted that he was doing what was best for me,” Olson said of Weiner. “I never really questioned that until someone else told me that there was reason to.”

I discovered Olson’s story in a cache of records related to an ongoing legal dispute between Weiner and St. Peter’s. I was struck by how similar his case was to that of another Weiner patient, Scot Warwick. Weiner had diagnosed Warwick with Stage 4 lung cancer and treated him with chemo and other therapies for 11 years, court records show; after Warwick died in 2020, his family learned, from both a biopsy and an autopsy, that he never had cancer. Weiner insisted that Warwick had cancer all those years and that other doctors “missed” the disease.

Olson’s diagnosis was similarly flimsy, and he had been treated over nearly the same period of time. But there was a key difference between the two men: Olson lived to tell his story.

Keep reading

High-fructose Corn Syrup is Everywhere — Scientists Say It May Make Cancerous Tumors Grow Faster

Eating fructose boosts the growth of cancerous tumors — by two-fold or greater in some cases — without changing body weight, fasting glucose or fasting insulin levels, according to a peer-reviewed study published Dec. 4 in Nature.

The authors of the study showed that dietary fructose promotes cancer tumor growth in mice that have melanoma, breast cancer and cervical cancer.

Fructose is a naturally occurring sugar found in some fruits, vegetables, honey and table sugar, according to the Mayo Clinic. The consumption of fructose has greatly increased in recent decades since food and beverage companies started routinely using high-fructose corn syrup as a sweetener, the authors said in their report.

According to the U.S. Food and Drug Administration (FDA), high-fructose corn syrup is derived from corn starch. Corn starch is naturally made of glucose, but added enzymes convert some of the glucose to fructose — which tastes sweeter.

Gary Patti, Ph.D. — a professor of genetics and medicine at Washington University, the senior director for the university’s Center for Metabolomics and Isotope Tracing, and the study’s corresponding author — told The Defender:

“We put animals with cancer on a high-fructose diet and then compared the progression of the disease with animals who were on standard diets. We also fed fructose to cancer cells in a dish.

“We were surprised that dietary fructose drove tumor growth in the animals but that the same cells could not use it as a nutrient when isolated in a dish.”

This led Patti and his co-authors to discover that fructose does not feed tumor growth directly. “Instead, the liver transforms fructose into other nutrients that then drive tumor growth indirectly,” Patti said.

The researchers were also surprised to see how dramatic an impact fructose had on tumors. “In some cases,” Patti said in a press release, “the growth rate of the tumors accelerated by two-fold or even higher … Eating a lot of fructose was clearly very bad for the progression of these tumors.”

Keep reading

FDA Updates Recall On Blood Pressure Medication Due To Possible Carcinogen

A third blood pressure medication was recalled across the United States in the past several weeks, according to a notice updated on the U.S. Food and Drug Administration’s (FDA) website on Dec. 16.

The notice said that New Jersey-based Aurobindo Pharma USA Inc. is recalling Nebivolol tablets in 2.5 milligram doses in 30-count bottles, which are only available by prescription. Nebivolol, a type of beta blocker, is used to treat high blood pressure.

The reason for the recall is because of the “presence of nitrosamine drug substance related impurity,” adding that discovered N-nitroso nebivolol levels are above the “acceptable intake limit,” it said. N-nitroso nebivolol is a nitrosamine and is considered mutagenic.

It was first initiated by Aurobindo earlier this month. The FDA classified the recall as Class II on Dec. 16, which occurs when there is a low chance of injury or death, and a possibility of “adverse events” that may have irreversible effects. They are issued if the product can cause medically reversible or temporary health problems—or if there is a small chance of serious health consequences.

The lot numbers being recalled are: NB0224001A and NB0224001B. It has an expiration date of April 2027 and a National Drug Code, or NDC, of 59651-137-30, according to the FDA.

Nitrosamines are compounds that can increase the risk of cancer in individuals if exposed to them above levels established by the FDA, or for long periods of time, the agency says on its website.

“A person taking a drug that contains nitrosamines at-or-below the acceptable daily intake limits every day for 70 years is not expected to have an increased risk of cancer,” the FDA adds.

People who are taking medications with possible “nitrosamine impurities should not stop taking their medications” and should instead speak with a health care professional.

Nitrosamines can be found in small levels in the environment and foods, including “meat, vegetables, and dairy products,” the FDA says.

Keep reading

Democrats Run Disinformation Campaign Blaming Musk and Trump for Child Cancer Research Cuts — Turns Out GOP House Passed Funding Bill in March But Schumer’s Senate Stalls for 9 Months Until Exposed

Democrats and their media allies launched a coordinated disinformation campaign this week, attempting to pin the blame for stalled pediatric cancer research funding on Elon Musk and President Donald Trump. The reality, however, reveals a much different story.

For months, the GOP-controlled House has been ahead of the curve, passing a comprehensive funding bill for pediatric cancer research back in March.

But Senate Majority Leader Chuck Schumer’s Democratic-controlled Senate let the legislation languish for nine months—only taking action after being exposed.

The firestorm began when a 1,500-page Democrat-Johnson continuing resolution (CR) packed with unrelated pork was shelved following public criticism from Musk and Trump, who vowed to challenge any Republican voting for the bloated measure.

House Minority Leader Hakeem Jeffries wasted no time launching an unfounded attack, claiming that Musk was single-handedly responsible for blocking pediatric cancer funding.

“Republicans are marching America to a painful government shutdown that will crash the economy and hurt working class Americans because they would rather enact massive tax cuts for their billionaire donors than fund cancer research for children,” Jeffries told the press.

Keep reading